Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 15c

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.60), $0.15 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $47.81 million.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49